E
DRIO icon

Ergoteles’s DarioHealth DRIO Stock Holding History

Ergoteles’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,792
Closed -$343K – 1644
2022
Q2 		$343K Buy
+2,792
New +$328K 0.01% 1035

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's DRIO Position: Q3 2022 in Review

Ergoteles sold out of DarioHealth (DRIO) in Q3 2022, closing a stake of 2,792 shares — an estimated $343K sold.

Ergoteles first reported a position in DRIO in Q2 2022 and held it in 1 quarter. The position peaked at $343K in Q2 2022. 45 funds tracked by Wall St. Rank hold DRIO as of Q3 2022.

  • Ergoteles reported no remaining DarioHealth position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 2,792 DarioHealth shares in Q3 2022, an estimated $343K.
  • Ergoteles first reported a position in DarioHealth in Q2 2022 and held it in 1 quarter.
  • Ergoteles's DarioHealth position peaked at $343K in Q2 2022.
  • 45 funds tracked by Wall St. Rank held DarioHealth as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.